Torno Capital, LLC Ultragenyx Pharmaceutical Inc. Call Options Transaction History
Torno Capital, LLC
- $1.56 Trillion
- Q1 2024
Call Options
2 transactions
Others Institutions Holding RARE
# of Institutions
291Shares Held
78.6MCall Options Held
570KPut Options Held
228K-
Vanguard Group Inc Valley Forge, PA8.7MShares$390 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.09MShares$318 Million5.31% of portfolio
-
Black Rock Inc. New York, NY5.24MShares$235 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.1MShares$184 Million0.03% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.86MShares$173 Million0.53% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.14B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...